Inhibikase Therapeutics, Inc.

NASDAQ (USD): Inhibikase Therapeutics, Inc. (IKT)

Last Price

3.29

Today's Change

+0.515 (18.52%)

Day's Change

2.86 - 3.69

Trading Volume

1,014,796

Financial
Reported Currency in USD
Market Cap

Market Cap

221 Million

Shares Outstanding

67 Million

Latest Quarter

Latest Quarter

30-Jun-2024 [Q2]

Announcement Date

14-Aug-2024

Reported Currency

USD

Revenue QoQ | YoY

- | -100.00%

NP QoQ | YoY

-6.67% | 14.16%

Latest Annual

Latest Annual

31-Dec-2023

Announcement Date

27-Mar-2024

Reported Currency

USD

Revenue | Net Profit

260,500.00 | -19,028,883.00

EPS | EPS Diluted

-3.57 Cent | -3.57 Cent

YoY

-6.28%

NP Margin

-7,304.75%

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment